Anna Kruczak

638 total citations
36 papers, 464 citations indexed

About

Anna Kruczak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Kruczak has authored 36 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Kruczak's work include Sarcoma Diagnosis and Treatment (9 papers), Breast Cancer Treatment Studies (7 papers) and Breast Lesions and Carcinomas (7 papers). Anna Kruczak is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Breast Cancer Treatment Studies (7 papers) and Breast Lesions and Carcinomas (7 papers). Anna Kruczak collaborates with scholars based in Poland, United States and Italy. Anna Kruczak's co-authors include Janusz Ryś, A Niezabitowski, Aleksandra Ambicka, Jerzy Lasota, Jerzy Mituś, Marian Reinfuss, Bożena Lackowska, Markku Miettinen, Maciej Kaczorowski and Małgorzata Chłopek and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Breast Cancer Research and Treatment.

In The Last Decade

Anna Kruczak

35 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kruczak Poland 12 211 158 125 120 111 36 464
Assia Bassarova Norway 15 193 0.9× 206 1.3× 97 0.8× 112 0.9× 108 1.0× 26 495
Sandeep Reddy United States 8 222 1.1× 159 1.0× 93 0.7× 150 1.3× 138 1.2× 18 458
Victor Kwan Min Lee Singapore 12 201 1.0× 202 1.3× 114 0.9× 110 0.9× 87 0.8× 43 511
Scott C. Bresler United States 10 237 1.1× 290 1.8× 121 1.0× 67 0.6× 181 1.6× 34 603
Rui Batısta Portugal 16 192 0.9× 280 1.8× 81 0.6× 51 0.4× 91 0.8× 29 719
M.T. Allende Spain 13 165 0.8× 184 1.2× 150 1.2× 122 1.0× 81 0.7× 25 589
Hyoun Wook Lee South Korea 16 196 0.9× 281 1.8× 117 0.9× 82 0.7× 130 1.2× 57 631
Bérengère Dadone France 11 120 0.6× 178 1.1× 172 1.4× 64 0.5× 102 0.9× 17 377
Adamantia Zizi-Sermpetzoglou Greece 12 271 1.3× 209 1.3× 76 0.6× 122 1.0× 82 0.7× 37 524
Valérie Dessirier France 12 125 0.6× 157 1.0× 74 0.6× 55 0.5× 84 0.8× 14 528

Countries citing papers authored by Anna Kruczak

Since Specialization
Citations

This map shows the geographic impact of Anna Kruczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kruczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kruczak more than expected).

Fields of papers citing papers by Anna Kruczak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kruczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kruczak. The network helps show where Anna Kruczak may publish in the future.

Co-authorship network of co-authors of Anna Kruczak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kruczak. A scholar is included among the top collaborators of Anna Kruczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kruczak. Anna Kruczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wysocka, Joanna, Agnieszka Adamczyk, Anna Kruczak, Joanna Niemiec, & Beata Sas-Korczyńska. (2020). High Ki-67 expression is a marker of poor survival in apocrine breast carcinoma. Polish Journal of Pathology. 71(2). 107–119. 2 indexed citations
2.
Kaznowska, Ewa, et al.. (2020). Synovial sarcoma of the stomach: case report and systematic review of the literature. Polish Journal of Pathology. 71(2). 181–193. 4 indexed citations
3.
Niemiec, Joanna, Agnieszka Adamczyk, Aleksandra Ambicka, et al.. (2018). Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas. Anticancer Research. 38(4). 1957–1965. 6 indexed citations
5.
Blecharz, Paweł, et al.. (2018). Molecular prognostic factors in early-stage cervical adenocarcinoma. Polish Journal of Pathology. 69(3). 285–291. 1 indexed citations
6.
Koczkowska, Magdalena, Beata S. Lipska‐Ziętkiewicz, Mariola Iliszko, et al.. (2017). Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma. Molecular Cytogenetics. 10(1). 7–7. 10 indexed citations
7.
Adamczyk, Agnieszka, Aleksandra Ambicka, Anna Janecka, et al.. (2016). Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting. Journal of Cancer. 8(1). 131–139. 15 indexed citations
9.
Puła, Bartosz, Andrzej Wojnar, Aleksandra Ambicka, et al.. (2013). Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma.. PubMed. 33(4). 1447–55. 14 indexed citations
10.
Kulpa, J, et al.. (2013). Indeks masy ciała (BMI) a stan zapalny u chorych na endometrialnego raka trzonu macicy. 49(3).
11.
Marczyk, Elżbieta, Anna Kruczak, Aleksandra Ambicka, et al.. (2011). The routine immunohistochemical evaluation in Paget disease of the nipple.. PubMed. 62(4). 229–35. 8 indexed citations
12.
Małecki, Krzysztof, Anna Mucha-Małecka, Janusz Ryś, et al.. (2010). Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment. Reports of Practical Oncology & Radiotherapy. 15(4). 87–92. 12 indexed citations
13.
Ryś, Janusz, et al.. (2009). Primary soft tissue giant cell tumour of the neck. Cytological and histological characteristics of the tumour and differential diagnosis.. PubMed. 60(2). 98–104; quiz 105. 4 indexed citations
14.
Ryś, Janusz, et al.. (2003). The role of CD44v3 expression in female breast carcinomas.. PubMed. 54(4). 243–7. 21 indexed citations
15.
Niezabitowski, A, Bożena Lackowska, Janusz Ryś, et al.. (2001). Prognostic Evaluation of Proliferative Activity and DNA Content in the Phyllodes Tumor of the Breast: Immunohistochemical and Flow Cytometric Study of 118 Cases. Breast Cancer Research and Treatment. 65(1). 77–85. 73 indexed citations
16.
Niezabitowski, A, et al.. (1999). Prognostic evaluation of cutaneous malignant melanoma: A clinicopathologic and immunohistochemical study. Journal of Surgical Oncology. 70(3). 150–160. 52 indexed citations
17.
Ryś, Janusz, Anna Kruczak, Mariola Iliszko, et al.. (1998). Sarcomatoid carcinoma (carcinosarcoma) of the gallbladder.. PubMed. 143(5-6). 321–5. 11 indexed citations
18.
Niezabitowski, A, et al.. (1995). Flow cytometric evaluation of Ki67 proliferative antigen in primary breast cancer.. PubMed. 46(1). 17–22. 1 indexed citations
19.
Niezabitowski, A, et al.. (1995). Relationship of histology, DNA-values and proliferative activity in unselected breast cancer patients (a preliminary study).. PubMed. 46(1). 23–8. 4 indexed citations
20.
Niezabitowski, A, et al.. (1994). Comparative flow cytometric DNA analysis on fresh and paraffin-embedded tumor tissue in different neoplasms.. PubMed. 45(3). 203–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026